| Ident. | Authors (with country if any) | Title |
|---|
| 000012 |
Frédéric Checler [France] ; Cristine Alves Da Costa [France] | p53 in neurodegenerative diseases and brain cancers |
| 000021 |
Shunro Fujiwara [France, Japon] ; Lynn Uhrig [France] ; Alexis Amadon [France] ; Béchir Jarraya [France] ; Denis Le Bihan [France] | Quantification of iron in the non-human primate brain with diffusion-weighted magnetic resonance imaging |
| 000028 |
Sylvia Navailles [France] ; Lea Milan [France] ; Hanane Khalki [France] ; Giuseppe Di Giovanni [Royaume-Uni, Malte] ; Mélanie Lagiere [France] ; Philippe De Deurwaerdere [France] | Noradrenergic Terminals Regulate L-DOPA-derived Dopamine Extracellular Levels in a Region-dependent Manner in Parkinsonian Rats |
| 000037 |
Tim Wagner [États-Unis] ; Uri Eden [États-Unis] ; Jarrett Rushmore [États-Unis] ; Christopher J. Russo [États-Unis] ; Laura Dipietro [États-Unis] ; Felipe Fregni [États-Unis] ; Stephen Simon [États-Unis] ; Stephen Rotman [États-Unis] ; Naomi B. Pitskel [États-Unis] ; Ciro Ramos-Estebanez [États-Unis] ; Alvaro Pascual-Leone [États-Unis] ; Alan J. Grodzinsky [États-Unis] ; Markus Zahn [États-Unis] ; Antoni Valero-Cabre [États-Unis, France, Espagne] | Impact of brain tissue filtering on neurostimulation fields: A modeling study |
| 000078 |
Julie Peron [Suisse] ; Sascha Frühholz [Suisse] ; Marc Verin [France] ; Didier Grandjean [Suisse] | Subthalamic nucleus: A key structure for emotional component synchronization in humans |
| 000095 |
A. Daoust [France] ; E. L. Barbier [France] ; S. Bohic [France] | Manganese enhanced MRI in rat hippocampus: A correlative study with synchrotron X-ray microprobe |
| 000100 |
Stefano Palminteri [France] ; Giulia Serra [France] ; Anne Buot [France] ; Liane Schmidt [France] ; Marie-Laure Welter [France] ; Mathias Pessiglione [France] | Hemispheric dissociation of reward processing in humans: Insights from deep brain stimulation |
| 000106 |
P. Peran [France, Italie] ; F. Nemmi [Italie] ; D. Meligne [France] ; D. Cardebat [France] ; A. Peppe [Italie] ; O. Rascol [France] ; C. Caltagirone [Italie] ; J. F. Demonet [Suisse] ; U. Sabatini [Italie] | Effect of levodopa on both verbal and motor representations of action in Parkinson's disease: A fMRI study |
| 000118 |
| Passeur d'espérance, itinéraire d'un parkinsonien |
| 000141 |
Jean-Pierre Benoit [France] | Micro- et nanotechnologies pour l'administration de médicaments au niveau cérébral : Les nanomédicaments réalités et perspectives |
| 000144 |
R. Carron [France] ; S. Chabardes [France] ; C. Hammond [France] | Les mécanismes d'action de la stimulation cérébrale à haute fréquence. Revue de la littérature et concepts actuels |
| 000161 |
V. Chhor [France] ; A.-L. Schang [France] ; G. Favrais [France] ; B. Fleiss [France, Royaume-Uni] ; P. Gressensa [France, Royaume-Uni] | Conséquences cérébrales à long terme de l'inflammation périnatale |
| 000163 |
V. Mendes Martins [France] ; J. Coste [France] ; P. Derost [France] ; M. Ulla [France] ; J. Gabrillargues [France] ; F. Durif [France] ; J. Chazal [France] ; J.-J. Lemaire [France] | Complications chirurgicales de la stimulation cérébrale profonde: expérience clinique à propos de 184 cas |
| 000173 |
WEI SONG [Canada] ; Hillel Zukor [Canada] ; Shih-Hsiung Lin [Canada] ; Adrienne Liberman [Canada] ; Ayda Tavitian [Canada] ; Jeannie Mui [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment |
| 000207 |
Thierry Burnouf [Taïwan, France, Allemagne] ; Ya-Po Kuo ; David Blum ; Sylvie Burnouf ; Chen-Yao Su | Human platelet concentrates: a source of solvent/detergent-treated highly enriched brain-derived neurotrophic factor |
| 000209 |
Faraj Terro [France] ; Amandine Magnaudeix [France] ; Marion Crochetet [France] ; Ludovic Martin [France] ; Sylvie Bourthoumieu [France] ; Cornelia-M. Wilson [France] ; Catherine Yardin [France] ; Philippe Leveque [France] | GSM-900 MHz at low dose temperature-dependently downregulates α-synuclein in cultured cerebral cells independently of chaperone-mediated-autophagy |
| 000245 |
C. Delpas | Stimulation cérébrale profonde. Succès confirmés ! |
| 000257 |
Julie Peron [France, Suisse] | Rôle fonctionnel du noyau sous-thalamique dans les processus émotionnels: que peut nous apprendre le modèle de la stimulation cérébrale dans la maladie de Parkinson ? |
| 000268 |
F. Le Jeune [France] | La tomoscintigraphie cérébrale au DaTSCAN |
| 000288 |
Delphine Michel-Monigadon [France] ; Virginie Bonnamain [France] ; Veronique Nerriere-Daguin [France] ; Anne-Sophie Dugast [France] ; Xavier Leveque [France] ; Martine Plat [France] ; Eric Venturi [France] ; Philippe Brachet [France] ; Ignacio Anegon [France] ; Bernard Vanhove [France] ; Isabelle Neveu [France] ; Philippe Naveilhan [France] | Trophic and immunoregulatory properties of neural precursor cells: Benefit for intracerebral transplantation : INTERACTION BETWEEN REPAIR, DISEASES, INFLAMMATION |
| 000322 |
Solène Genty [France] ; Stephane Derrey [France] ; Sophie Pouplin [France] ; Romain Lefaucheur [France] ; Nathalie Chastan [France] ; Emmanuel Gerardin [France] ; David Maltete [France] | Pain due to osteoarthritis may impair the early outcome of deep brain stimulation in Parkinson's disease |
| 000335 |
Michel Benoit [France] ; Philippe H. Robert [France] | Imaging correlates of apathy and depression in Parkinson's disease |
| 000354 |
Thierry Soulas [France] ; Serge Sultan [France] ; Jean-Marc Gurruchaga [France] ; Stéphane Palfi [France] ; Gilles Fenelon [France] | Depression and Coping as Predictors of Change After Deep Brain Stimulation in Parkinson's Disease |
| 000376 |
Pauline Narme [France] ; Harold Mouras [France] ; Gwénolé Loas [France] ; Pierre Krystkowiak [France] ; Martine Roussel [France] ; Muriel Boucart [France] ; Olivier Godefroy [France] | Vers une approche neuropsychologique de l'empathie |
| 000415 |
Bruno Millet [France] ; Marc Verin [France] ; Dominique Drapier [France] | Indications psychiatriques de la stimulation cérébrale profonde |
| 000440 |
Fanny Schmiijt [France] ; Gael Le Douaron [France] ; Pierre Champy [France] ; Majid Amar [France] ; Blandine Seon-Meniel [France] ; Rita Raisman-Vozari [France] ; Bruno Figadere [France] | Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons |
| 000441 |
Julie Deguil [France] ; François Chavant [France] ; Claire Lafay-Chebassier [France] ; Marie-Christine Perault-Pochat [France] ; Bernard Fauconneau [France] ; Stéphanie Pain [France] | Time course of MPTP toxicity on translational control protein expression in mice brain |
| 000488 |
Stephane Besnard [France] ; Michael Decressac [France] ; Pierre Denise [France] | In-vivo deep brain recordings of intranigral grafted cells in a mouse model of Parkinson's disease |
| 000489 |
Thomas Z. Rams Y [Danemark] ; Martin Skov | How genes make up your mind: Individual biological differences and value-based decisions |
| 000515 |
Masahiro Shin [France, Japon] ; Marcello Faria Penholate [France] ; Jean-Pascal Lefaucheur [France] ; Jean-Marc Gurruchaga [France] ; Pierre Brugieres [France] ; Jean-Paul Nguyen [France] ; Robert R. Goodman | Assessing Accuracy of the Magnetic Resonance Imaging-Computed Tomography Fusion Images to Evaluate the Electrode Positions in Subthalamic Nucleus After Deep-Brain Stimulation. Commentary |
| 000517 |
Roberta Cavalcanti-Kwiatkoski [Brésil] ; Rita Raisman-Vozari [France] ; Laure Ginestet [France] ; Elaine Del Bel [Brésil] | Altered expression of neuronal nitric oxide synthase in weaver mutant mice |
| 000555 |
A. Kreisler [France] ; L. Defebvre [France] ; A. Duhamel [France] ; P. Lecouffe [France] ; K. Dujardin [France] ; M. Steinling [France] ; F. Pasquier [France] ; A. Destee [France] | Intérêt de l'analyse factorielle discriminante pour classer les syndromes parkinsoniens à partir de la tomoscintigraphie d'émission monophotonique |
| 000556 |
A. Eusebio [France] ; J. Micallef-Roll [France] | Glutamate et grandes fonctions cérébrales |
| 000599 |
Benedicte Ballanger [Canada, France] ; Marjan Jahanshahi [Royaume-Uni] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France] | PET functional imaging of deep brain stimulation in movement disorders and psychiatry |
| 000603 |
Mélissa Tir [France] ; Christine Delmaire [France] ; Vianney Le Thuc [France] ; Alain Duhamel [France] ; Alain Destée [France] ; Jean-Pierre Pruvo [France] ; Luc Defebvre [France] | Motor-Related Circuit Dysfunction in MSA-P : Usefulness of Combined Whole-Brain Imaging Analysis |
| 000610 |
Igor Lima Maldonado [France] ; Thomas Roujeau [France] ; Laura Cif [France] ; Victoria Gonzalez [France] ; Hassan Ei-Fertit [France] ; Xavier Vasques [France] ; Alain Bonafe [France] ; Phillippe Coubes [France] ; Philip A. Starr ; Roy A. E. Bakay ; Robert R. Goodman | MAGNETIC RESONANCE-BASED DEEP BRAIN STIMULATION TECHNIQUE: A SERIES OF 478 CONSECUTIVE IMPLANTED ELECTRODES WITH No PERIOPERATIVE INTRACEREBRAL HEMORRHAGE. COMMENTARIES |
| 000615 |
Hillel Zukor [Canada] ; WEI SONG [Canada] ; Adrienne Liberman [Canada] ; JEANNIE MUI [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | HO-1-mediated macroautophagy : a mechanism for unregulated iron deposition in aging and degenerating neural tissues |
| 000621 |
E. Garbayo [Espagne] ; C. N. Montero-Menei [France] ; E. Ansorena [Espagne] ; J. L. Lanciego [Espagne] ; M. S. Aymerich [Espagne] ; M. J. Blanco-Prieto [Espagne] | Effective GDNF brain delivery using microspheres-A promising strategy for Parkinson's disease |
| 000628 |
Sébastien Robert Montel [France] ; Catherine Bungener [France] ; Konstantin V. Slavin [États-Unis] | Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus. Commentary |
| 000629 |
Pierre Payoux [France] ; Philippe Remy [France] ; Malika Miloudi [France] ; Jean-Luc Houeto [France] ; Claudio Stadler [France] ; Boulos-Paul Bejjani [France] ; Jérome Yelnik [France] ; Yves Samson [France] ; Olivier Rascol [France] ; Yves Agid [France] ; Philippe Damier [France] | Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease |
| 000638 |
Karim Farid [France] ; Igor Sibon [France] ; Dominique Guehl [France] ; Emmanuel Cuny [France] ; Pierre Burbaud [France] ; Michèle Allard [France] | Brain Dopaminergic Modulation Associated with Executive Function in Parkinson's Disease |
| 000649 |
Eric Bardinet [France] ; Manik Bhattacharjee [France] ; Didier Dormont [France] ; Bernard Pidoux [France] ; Grégoire Malandain [France] ; Michael Schüpbach [France] ; Nicholas Ayache [France] ; Philippe Cornu [France] ; Yves Agid [France] ; Jérome Yelnik [France] | A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease : Clinical article |
| 000685 |
André Galinowski [France] ; May Ghossoub [France] ; Thomas Weber [France] | Les troubles anxieux dans la maladie de Parkinson |
| 000718 |
Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis] | Striatal histone modifications in models of levodopa-induced dyskinesia |
| 000723 |
Imane Nafia [France] ; Diane B. Re [France] ; Frédérique Masmejean [France] ; Christophe Melon [France] ; Philippe Kachidian [France] ; Lydia Kerkerian-Le Goff [France] ; André Nieoullon [France] ; Laurence Had-Aissouni [France] | Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction |
| 000733 |
Sorin Breit [France, Allemagne] ; Jean-Francois Lebas [France] ; Adnan Koudsie [France] ; Jörg Schulz [Allemagne] ; Abdelhamid Benazzouz [France] ; Pierre Pollak [France] ; Alim-Louis Benabid [France] ; Roy A. Bakay ; Philip A. Starr ; Andres M. Lozano | PRETARGETING FOR THE IMPLANTATION OF STIMULATION ELECTRODES INTO THE SUBTHALAMIC NUCLEUS : A COMPARATIVE STUDY OF MAGNETIC RESONANCE IMAGING AND VENTRICULOGRAPHY |
| 000735 |
Patrick Emond [France] ; Denis Guilloteau [France] ; Sylvie Chalon [France] | PE21 : A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter |
| 000743 |
Gabor G. Kovacs [Autriche, Hongrie] ; Irina Alafuzoff [Finlande] ; Safa Al-Sarraj [Royaume-Uni] ; Thomas Arzberger [Allemagne] ; Nenad Bogdanovic [Suède] ; Sabina Capellari [Italie] ; Isidro Ferrer [Espagne] ; Ellen Gelpi [Autriche] ; Viktor Kövari [Hongrie] ; Hans Kretzschmar [Allemagne] ; Zoltan Nagy [Hongrie] ; Piero Parchi [Italie] ; Danielle Seilhean [France] ; Hilkka Soininen [Finlande] ; Claire Troakes [Royaume-Uni] ; Herbert Budka [Autriche] | Mixed Brain Pathologies in Dementia : The BrainNet Europe Consortium Experience |
| 000752 |
Sarah Vautier [France] ; Aline Milane [France] ; Christine Fernandez [France] ; Marion Buyse [France] ; Helene Chacun [France] ; Robert Farinotti [France] | Interactions between antiparkinsonian drugs and ABCB1/P-glycoprotein at the blood-brain barrier in a rat brain endothelial cell model |
| 000758 |
Christine Winter [Allemagne] ; Christoph Lemke [Allemagne] ; Reinhard Sohr [Allemagne] ; Wassilios Meissner [Allemagne, France] ; Daniel Harnack [Allemagne] ; Georg Juckel [Allemagne] ; Rudolf Morgenstern [Allemagne] ; Andreas Kupsch [Allemagne] | High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat |
| 000782 |
Elsa Gisquet [France] | Cerebral implants and Parkinson's disease : A unique form of biographical disruption? |
| 000800 |
Gabor Szenasi [Hongrie] ; Miklos Vegh [Hongrie] ; Geza Szabo [Hongrie] ; Szabolcs Kertesz [Hongrie] ; Gabor Kapus [Hongrie] ; Mihaly Albert [Hongrie] ; Zoltan Greff [Hongrie] ; Istvan Ling [Hongrie] ; Jozsef Barkoczy [Hongrie] ; Gyula Simig [Hongrie] ; Michael Spedding [France] ; Laszlo G. Jr Harsing [Hongrie] | 2,3-Benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects |
| 000871 |
V. Vialou [France] ; L. Balasse [France] ; S. Dumas [France] ; B. Giros [France] ; S. Gautron [France] | Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain |
| 000892 |
Mehdi Tafti [Suisse] ; Norbert B. Ghyselinck [France] | Functional Implication of the Vitamin A Signaling Pathway in the Brain |
| 000980 |
Sorin Breit [France, Allemagne] ; Jean-Francois Lebas [France] ; Adnan Koudsie [France] ; Jörg Schulz [Allemagne] ; Abdelhamid Benazzouz [France] ; Pierre Pollak [Allemagne] ; Alim-Louis Benabid [France] ; Roy A. Bakay ; Philip A. Starr ; Andres M. Lozano | Pretargeting for the implantation of stimulation electrodes into the subthalamic nucleus : A comparative study of magnetic resonance imaging and ventriculography. Commentary |
| 000987 |
Neil V. Morgan [Royaume-Uni] ; Shawn K. Westaway [États-Unis] ; Jenny E. V. Morton [Royaume-Uni] ; Allison Gregory [États-Unis] ; Paul Gissen [Royaume-Uni] ; Scott Sonek [États-Unis] ; Hakan Cangul [Royaume-Uni, Turquie] ; Jason Coryell [États-Unis] ; Natalie Canham [Royaume-Uni] ; Nardo Nardocci [Italie] ; Giovanna Zorzi [Italie] ; Shanaz Pasha [Royaume-Uni] ; Diana Rodriguez [France] ; Isabelle Desguerre [France] ; Amar Mubaidin [Jordanie] ; Enrico Bertini [Italie] ; Richard C. Trembath [Royaume-Uni] ; Alessandro Simonati [Italie] ; Carolyn Schanen [États-Unis] ; Colin A. Johnson [Royaume-Uni] ; Barbara Levinson [États-Unis] ; C. Geoffrey Woods [Royaume-Uni] ; Beth Wilmot [États-Unis] ; Patricia Kramer [États-Unis] ; Jane Gitschier [États-Unis] ; Eamonn R. Maher [Royaume-Uni] ; Susan J. Hayflick [États-Unis] | PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron |
| 000A20 |
Alice Villeger [France] ; Lemlih Ouchchane [France] ; Jean-Jacques Lemaire [France] ; Jean-Yves Boire [France] | Data fusion and fuzzy spatial relationships for locating deep brain stimulation targets in magnetic resonance images |
| 000A57 |
France Haour [France] | Mécanismes de l'effet placebo et du conditionnement : Données neurobiologiques chez l'homme et l'animal |
| 000A59 |
Jean-Philippe Pin [France] | Moduler l'action du glutamate dans le cerveau : De nouvelles pistes ouvertes grâce aux récepteurs métabotropiques |
| 000A70 |
Constance Hammond [France] | La stimulation à haute fréquence dans la maladie de Parkinson : effets à court et long termes |
| 000A75 |
Alain Bottero [France] | L'éthique au secours de la psychochirurgie ? : Présence du corps |
| 000B14 |
Yan-Qin Shen [République populaire de Chine, France] ; Guillaume Hebert [France] ; Yun Su [France] ; Elizabeth Moze [France] ; Pierre J. Neveu [France] ; Kang-Sheng Li [République populaire de Chine] | In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization |
| 000B34 |
C. Haegelen [France] ; M. Verin [France] ; B. Aubert Broche [France] ; F. Prigent [France] ; P. Jannin [France] ; B. Gibaud [France] ; X. Morandi [France] | Does subthalamic nucleus stimulation affect the frontal limbic areas? A single-photon emission computed tomography study using a manual anatomical segmentation method |
| 000B94 |
Evo K. Lindersson [Danemark] ; Peter H Jrup [Danemark] ; WEI PING GAI [Australie] ; Daniel Locker [France] ; Davy Martin [France] ; Poul Henning Jensen [Danemark] | α-Synuclein filaments bind the transcriptional regulator HMGB-I |
| 000B99 |
M. Szczerbowska-Boruchowska [Pologne] ; M. Lankosz [Pologne] ; J. Ostachowicz [Pologne] ; D. Adamek [Pologne] ; A. Krygowska-Wajs [Pologne] ; B. Tomik [Pologne] ; A. Szczudlik [Pologne] ; A. Simionovlcl [France] ; S. Bohic [France] | Topographic and quantitative microanalysis of human central nervous system tissue using synchrotron radiation |
| 000C52 |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Georgy M. Nagy [Hongrie] | Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains |
| 000C78 |
| Histoire des éponymes en psychogériatrie. |
| 000C81 |
I. Arnulf [France] | Troubles du sommeil au cours des synucléopathies et des taupathies |
| 000C94 |
J.-J. Hauw [France] ; C. Hausser-Hauw [France] ; C. Duyckaerts [France] | Neuropathologie des taupathies et synucléinopathies et neuroanatomie des troubles du sommeil : un challenge à relever |
| 000D05 |
Alim-Louis Benabid [France] | La stimulation cérébrale profonde à haute fréquence |
| 000E18 |
| Déficiences motrices et situations de handicaps : Aspects sociaux, psychologiques, médicaux, techniques, troubles associés. |
| 000E50 |
P.-C. Nguimfack Mbodie [France] | La théorie de l'excitotoxicité du glutamate et l'implication potentielle des radicaux libres dans l'étiopathogénie de la schizophrénie apporte-t-elle un éclairage nouveau sur les liens entre : prédisposition génétique, facteurs environnementaux et biologie dans le déterminisme de ce trouble ? |
| 000E51 |
André Galinowski [France] ; Marie-Laure Paillere-Martinot [France] | La stimulation magnétique transcrânienne répétée : Vers un nouvel outil thérapeutique en psychiatrie : Les avancées scientifiques en psychiatrie |
| 000E52 |
Alim-Louis Benabid [France] ; Christine Maillard | La stimulation cérébrale profonde étend ses indications |
| 000E75 |
Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France] | Treatment results: Parkinson's disease |
| 000F01 |
Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Postoperative management of subthalamic nucleus stimulation for Parkinson's disease |
| 000F11 |
Bernard Pillon [France] | Neuropsychological assessment for management of patients with deep brain stimulation |
| 000F21 |
Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] | Mechanisms of deep brain stimulation |
| 000F22 |
Jerrold L. Vitek [États-Unis] | Mechanisms of deep brain stimulation: Excitation or inhibition |
| 000F29 |
André Parent [Canada] ; Martin Parent [Canada] ; Véronique Leroux-Hugon [France] | Jules Bernard Luys: A singular figure of 19th Century neurology |
| 000F31 |
Jens Volkmann [Allemagne] ; Jan Herzog [Allemagne] ; Florian Kopper [Allemagne] ; Güntner Deuschl [Allemagne] | Introduction to the programming of deep brain stimulators |
| 000F50 |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Yukihiro Akao [Japon] ; HONG YI [Japon] | Dopamine-derived endogenous N-methyl-(R)-salsolinol its role in Parkinson's disease |
| 000F51 |
Diego Centonze [Italie] ; Alessandro Usiello [France] ; Paolo Gubellini [Italie] ; Antonio Pisani [Italie] ; Emiliana Borrelli [France] ; Giorgio Bernardi [Italie] ; Paolo Calabresi [Italie] | Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors |
| 000F54 |
Jens Volkmann [Allemagne] ; Reiner Benecke [Allemagne] | Deep brain stimulation for dystonia: Patient selection and evaluation |
| 000F55 |
Anthony E. Lang [Canada] ; Hakan Widner [Suède] | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
| 000F59 |
Marwan I. Hariz [Suède] | Complications of deep brain stimulation surgery |
| 000F65 |
Yoshiaki Furukawa [Canada] ; Sophie Vigouroux [France] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; LEE ANG [Canada] ; Marièle Briand [France] ; Stephen J. Kish [Canada] ; Yves Briand [France] | Brain proteasomal function in sporadic Parkinson's disease and related disorders |
| 001005 |
Roger G. Boulu [France] ; Christian Mesenge ; Christiane Charriaut-Marlangue ; Catherine Verrecchia ; Michel Plotkine ; Michel Bourel ; Roger Nordmann ; Claude Dreux ; Jacques-Louis Binet ; Gabriel Blancher | Mort neuronale : rôle potentiel d'une enzyme nucléaire, la poly(ADP-ribose) polymérase. Discussion |
| 001006 |
F. Clostre [France] | Mitochondries : Découvertes physiopathologiques récentes et nouvelles perspectives thérapeutiques |
| 001023 |
M. Pelletier [France] ; F. M. Vallette [France] | Apoptose et maladies neurodégénératives |
| 001031 |
A. Autret [France] ; B. Lucas [France] ; K. Mondon [France] ; C. Hommet [France] ; Ph. Corcia [France] ; D. Saudeau [France] ; B. De Toffol [France] | Sleep and brain lesions: a critical review of the literature and additional new cases |
| 001077 |
Olivier Rascol [France] ; Nelly Fabre [France] | Dyskinesia: L-dopa-induced and tardive dyskinesia |
| 001090 |
Olivier Guillin [France] ; Jorge Diaz [France] ; Patrick Carroll [France] ; Nathalie Griffon [France] ; Jean-Charles Schwartz [France] ; Pierre Sokoloff [France] | BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization |
| 001128 |
G. Fenelon [France] | Maladie de parkinson et examens complémentaires. Quels sont-ils, sont-ils nécessaires, quand le sont-ils ? |
| 001146 |
Bertrand Bloch [France] | La dopamine dans tous ses états |
| 001156 |
D. Ranoux [France] | Dépression et maladie de Parkinson |
| 001167 |
R. Kumar [Canada] ; A. E. Lang [Canada] ; M. C. Rodriguez-Oroz [Espagne] ; A. M. Lozano [Canada] ; P. Limousin [France] ; P. Pollak [France] ; A. L. Benabid [France] ; J. Guridi [Espagne] ; E. Ramos [Espagne] ; C. Van Der Linden [Belgique] ; A. Vandewalle [Belgique] ; J. Caemaert [Belgique] ; E. Lannoo [Belgique] ; D. Van Den Abbeele [Belgique] ; G. Vingerhoets [Belgique] ; M. Wolters [Belgique] ; J. A. Obeso [Espagne] | eep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease |
| 001188 |
M. Grandbois [Canada] ; M. Morissette [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice |
| 001193 |
S. Thobois [France] ; P. F. Dominey [France] ; J. Decety [France] ; P. Pollak [France] ; M. C. Gregoire [France] ; D. Le Bars [France] ; E. Broussolle [France] | Motor imagery in normal subjects and in asymmetrical Parkinson's disease : a PET study |
| 001197 |
Abdelhamid Benazzouz [France] ; Mark Hallett [États-Unis] | Mechanism of action of deep brain stimulation |
| 001205 |
A.-M. Bonnet [France] | Involvement of non-dopaminergic pathways in Parkinson's disease : Pathophysiology and therapeutic implications |
| 001209 |
Frédéric Dolle [France] ; Michel Bottlaender [France] ; Stéphane Demphel [France] ; Patrick Emond [France] ; Chantal Fuseau [France] ; Christine Coulon [France] ; Michele Ottaviani [France] ; Héric Valette [France] ; Christian Loc'H [France] ; Christer Halldin [Suède] ; Laurent Mauclaire [France] ; Denis Guilloteau [France] ; Bernard Maziere [France] ; Christian Crouzel [France] | Highly efficient synthesis of [11C]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET |
| 001228 |
N. Schulmann-Choron [France] ; P. Chevallier [France] ; J. De Ceaurriz [France] ; C. Souleau [France] | Determination of selenium in rat brain by synchrotron radiation X-ray fluorescence |
| 001229 |
A. L. Benabid [France] ; P. Krack [France] ; A. Benazzouz [France] ; P. Limousin [France] ; A. Koudsie [France] ; P. Pollak [France] | Deep brain stimulation of the subthalamic nucleus for Parkinson's disease : Methodologic aspects and clinical criteria |
| 001234 |
M.-J. Ribeiro [France, Portugal] ; P. Remy [France] ; B. Bendriem [États-Unis, France] ; P. Almeida [France, Portugal] ; V. Brulon [France] ; Y. Samson [France] ; B. Maziere [France] ; R. Trebossen [France] | Comparison of clinical data sets acquired on different tomographs using 6-18F-L-dopa |
| 001235 |
W.-J. Gu [France] ; N. Abbas [France] ; M. Z. Lagunes [France] ; A. Parent [France] ; L. Pradier [France] ; G. A. Bohme [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; R. Raisman-Vozari [France] ; A. Brice [France] | Cloning of rat parkin cDNA and distribution of parkin in rat brain |
| 001244 |
P. E. Newman [France] | Alzheimer's disease revisited |
| 001251 |
| «Parcellisation» systématique du cerveau en volumes d'intérêt. Le cas des structures profondes |
| 001291 |
B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; L. Thivard [France] ; A.-M. Bonnet [France] ; D. Dormont [France] ; P. Cornu [France] ; B. Pidoux [France] ; Y. Samson [France] ; Yves Agid [France] | Transient acute depression induced by high-frequency deep-brain stimulation |
| 001316 |
S. Bourgoin [France] ; S. Rostaing-Rigattieri [France] ; J.-P. Nguyen [France] ; E. Berberich [France] ; P. Duvaldestin [France] ; C.-M. Fattaccini [France] ; M. Hamon [France] ; F. Cesselin [France] | Opposite changes in dopamine metabolites and met-enkephalin levels in the ventricular CSF of patients subjected to thalamic electrical stimulation |
| 001328 |
C. Fillebeen [France] ; V. Mitchell [France] ; D. Dexter [Royaume-Uni] ; M. Benaissa [France] ; J.-C. Beauvillain [France] ; G. Spik [France] ; A. Pierce [France] | Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment |
| 001335 |
R. G. Brown [Royaume-Uni] ; P. L. Dowsey [Royaume-Uni, France] ; P. Brown [Royaume-Uni] ; M. Jahanshahi [Royaume-Uni] ; P. Pollak [France] ; A. L. Benabid [France] ; M. C. Rodriguez-Oroz [Espagne] ; J. Obeso [Espagne] ; J. C. Rothwell [Royaume-Uni] | Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease |
| 001336 |
H. Valette [France] ; M. Bottlaender [France] ; F. Dolle [France] ; I. Guenther [France] ; C. Fuseau [France] ; C. Coulon [France] ; M. Ottaviani [France] ; C. Crouzel [France] | Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380 |
| 001351 |
F. A. Dajas-Bailador [Uruguay] ; M. Asencio [Chili] ; C. Bonilla [Uruguay] ; M. C. Scorza [Uruguay] ; C. Echeverry [Uruguay] ; M. Reyes-Parada [Uruguay] ; R. Silveira [Uruguay] ; P. Protais [France] ; G. Russell [Nouvelle-Zélande] ; B. K. Cassels [Chili] ; F. Dajas [Uruguay] | Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission |
| 001377 |
| Synthèse de radioligands marqués au brome-76 et au carbone-11 pour l'étude des récepteurs N-Méthyl-D-Aspartate par Tomographie d'Emission de Positons |
| 001378 |
| Canaux K+ et neurodégénérescence : implication des canaux K+ sensibles à l'ATP et des canaux K+ régulés par les protéines G dans la dégénérescence neuronale |
| 001407 |
C. Brefel-Courbon [France] ; C. Thalamas [France] ; H. Peyro Saint Paul [France] ; J.-M. Senard [France] ; J.-L. Montastruc [France] ; O. Rascol [France] | α2-Adrenoceptor antagonists: A new approach to Parkinson's disease? |
| 001414 |
E. Bezard [France] ; T. Boraud [France] ; C. Imbert [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France] | Towards a dynamic approach of experimental parkinsonism |
| 001431 |
J. Le Houezec [France] | Nicotine : abused substance and therapeutic agent |
| 001433 |
E. X. Albuquerque [États-Unis, Brésil] ; E. F. R. Pereira [États-Unis] ; M. F. M. Braga [États-Unis, Brésil] ; H. Matsubayashi [États-Unis] ; M. Alkondon [États-Unis] | Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine |
| 001434 |
F. Macar [France] | Neural bases of internal timers : A brief overview |
| 001444 |
W. Krezel [France] ; N. Ghyselinck [France] ; T. A. Samad [France] ; V. Dupe [France] ; P. Kastner [France] ; E. Borrelli [France] ; P. Chambon [France] | Impaired locomotion and dopamine signaling in retinoid receptor mutant mice |
| 001477 |
| Développement de médicaments radiopharmaceutiques émetteurs de rayonnements gamma pour l'exploration du transporteur de la dopamine dans le système nerveux central |
| 001487 |
D. Ho [États-Unis] ; R. Sapolsky [États-Unis] | Thérapie génique et système nerveux |
| 001533 |
J. P. Francke [France] ; R. Sigal [France] ; P. Martinat [France] ; J. P. Pruvo [France] | Anatomie sérielle et IRM des noyaux de la base et du thalamus |
| 001559 |
B. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; A. M. Bonnet [France] ; M. Vidailhet [France] ; D. Dormont [France] ; B. Pidoux [France] ; P. Cornu [France] ; C. Marsault [France] ; Yves Agid [France] | Pallidal stimulation for Parkinson's disease : Two targets? |
| 001560 |
G. Ali Qureshi [Suède] ; S. M. Baig [Pakistan] ; S. H. Parvez [France] | Neurotoxicity and possible roles of aspartic acid, glutamic acid and GABA in some neurologic disorders |
| 001573 |
C. Gargalidis-Moudanos [France] ; N. Pizzinat ; F. Javoy-Agid ; A. Remaury ; A. Parini | I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease |
| 001578 |
S. Vyas [France] ; F. Javoy-Agid [France] ; M.-T. Herrero [Espagne] ; O. Strada [France] ; F. Boissiere [France] ; U. Hibner [France] ; Yves Agid [France] | Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders |
| 001585 |
E. Bezard [France] ; T. Boraud [France] ; B. Bioulac [France] ; C. E. Gross [France] | Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism |
| 001597 |
E. Peltekian [France] ; E. Parrish [France] ; C. Bouchard [France] ; M. Peschanski [France] ; F. Lisovoski [France] | Adenovirus-mediated gene transfer to the brain : methodological assessment |
| 001602 |
| Un organe de contrôle inspiré de la neuromodulation pour les Réseaux à Propagation Guidée |
| 001609 |
| Déficiences motrices et handicaps : Aspects sociaux, psychologiques, médicaux, techniques et législatifs, troubles associés |
| 001639 |
S. Naimi [France] ; R. Jeny [France] ; P. Hantraye [France] ; M. Peschanski [France] ; D. Riche [France] | Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain |
| 001652 |
S. Hunot [France] ; V. Bernard [France] ; B. Faucheux [France] ; F. Boissiere [France] ; E. Leguern [France] ; C. Brana [France] ; P. P. Gautris [France] ; J. Guerin [France] ; B. Bloch [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain : a post mortem in situ hybridization study with special reference to Parkinson's disease |
| 001663 |
A. L. Benabid [France] ; P. Pollak ; DONGMING GAO ; D. Hoffmann ; P. Limousin ; E. Gay ; I. Payen ; ABDELHAMID BENAZZOUZ | Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders |
| 001665 |
L. Taupenot [France] ; J. Ciesielski-Treska [France] ; G. Ulrich [France] ; S. Chasserot-Golaz [France] ; D. Aunis [France] ; M.-F. Bader [France] | Chromogranin a triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells |
| 001670 |
F. N. Bolkenius [France] ; J. Verne-Mismer [France] ; J. Wagner [France] ; J. M. Grisar [France] | Amphiphilic α-tocopherol analogues as inhibitors of brain lipid peroxidation |
| 001672 |
M.-E. Llau [France] ; G. Durrieu [France] ; M.-A. Tran [France] ; J.-M. Senard [France] ; O. Rascol [France] ; J.-L. Montastruc [France] | A study of dopaminergic sensitivity in Parkinson's disease : Comparison in ''de novo'' and levodopa-treated patients |
| 001679 |
| Synthèse et marquage au carbone-11 et au fluor-18 d'inhibiteurs de capture de la Dopamine pour une étude du système dopaminergique en Tomographie par Emission de Positons |
| 001687 |
C. Wallays [France] ; A. Feve ; F. Boudghene [France] ; G. Fenelon ; A. Guillard ; J.-M. Bigot [France] | Lésions cérébrales hypoxiques aspects TDM et IRM. A propos de 20 cas. Vulnérabilité sélective du striatopallidum |
| 001699 |
F. Tison [Royaume-Uni, France] ; G. K. Wenning [Royaume-Uni] ; S. E. Daniel ; N. P. Quinn [Royaume-Uni] | Atrophie multisystématisée avec corps de Lewy |
| 001702 |
L. Defebvre [France] ; P. Lecouffe ; A. Destee ; P. Houdart ; M. Steinling | Tomographic measurements of regional cerebral blood flow in progressiv supranuclear palsy and Parkinson's disease |
| 001705 |
L. Lebreton [France] ; O. Curet [France] ; S. Gueddari [France] ; FATHI MAZOUZ [France] ; S. Bernard [France] ; C. Burstein [France] ; R. Milcent [France] | Selective and potent monoamine oxidase type B inhibitors : 2-substituted 5-aryltetrazole derivatives |
| 001719 |
C. Geny [France] ; SOUAD NAIMI-SADAOUI [France] ; ABD EL MADJID BELKADI [France] ; R. Jeny [France] ; MOURAD KAMMOUN [France] ; M. Peschanski [France] | Microglial chimaerism in human xenografts to the rat brain |
| 001728 |
P. Barneoud [France] ; S. Parmentier ; M. Mazadier ; J. M. Miquet ; A. Boireau ; P. Dubedat ; J.-C. Blanchard | Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat |
| 001732 |
J. Blin [France] ; P. Mazetti ; B. Mazoyer [France] ; S. Rivaud ; S. Ben Ayed [France] ; C. Malapani ; B. Pillon ; Yves Agid [France] | Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy ? |
| 001734 |
C. Jolivalt [France] ; A. Minn [France] ; M. Vincent-Viry [France] ; M.-M. Galteau [France] ; G. Siest [France] | Dextromethorphan O-demethylase activity in rat brain microsomes |
| 001769 |
B. Dubois [France] ; C. Malapani ; M. Verin ; P. Rogelet ; B. Deweer ; B. Pillon | Fonctions cognitives et noyaux gris centraux : le modèle de la maladie de Parkinson |
| 001772 |
J. C. Baron [France] | Conséquences des lésions des noyaux gris centraux sur l'activité métabolique cérébrale : implications cliniques |
| 001783 |
S. Holemans [Belgique] ; F. Javoy-Agid [France] ; Yves Agid [France] ; F. De Paermentier ; E. C. Laterre [Belgique] ; J.-M. Maloteaux [Belgique] | Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease |
| 001791 |
O. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; N. Fabre [France] ; J. M. Senard [France] ; J. L. Montastruc [France] ; P. Calsis [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France] | Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa |
| 001810 |
P. Hantraye [France] ; E. Brouillet | Chronic treatment with mitochondrial toxins in primates as experimental models of Parkinson's and Huntington's diseases |
| 001876 |
A. Kastner [France] ; E. C. Hirsch ; M. T. Herrero ; F. Javoy-Agid ; Yves Agid [France] | Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease |
| 001889 |
B. A. Faucheux [France] ; E. C. Hirsch [France] ; J. Villares [France] ; F. Selimi [France] ; A. Mouatt-Prigent [France] ; F. Javoy-Agid [France] ; J. J. Hauw [France] ; Yves Agid [France] | Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease |
| 001895 |
J. Villares [France] ; B. Faucheux ; O. Strada ; E. C. Hirsch ; Yves Agid [France] ; F. Javoy-Agid | Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem |
| 001901 |
| Synthèses chimiques et études biochimiques de nouveaux inhibiteurs réversibles et sélectifs des monoamines oxydases A et B. Marquage d'un IMAO B à l'iode 125 et étude de sa biodistribution |
| 001945 |
P. P. Michel [France] ; S. Vyas ; Yves Agid [France] | Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains |
| 001948 |
O. Rascol [France] ; U. Sabatini ; F. Chollet ; P. Celsis ; J.-L. Montastruc ; J.-P. Marc-Vergnes ; A. Rascol | Supplementary and primary sensory motor area activity in Parkinson's disease : regional cerebral blood flow changes during finger movements and effects of apomorphine |
| 001949 |
F. Durif [France] ; P. Pollak [France] ; M. Hommel ; C. Ardouin ; J. F. Le Bas ; G. Crouzet ; J. Perret | Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson's disease |
| 001956 |
F. Parker [France] ; N. Tzourio ; S. Blond ; H. Petit ; B. Mazoyer | Evidence for a common network of brain structures involved in Parkinsonian tremor and voluntary repetitive movement |
| 001957 |
L. J. Anghileri [France] | Effects of complexes iron and aluminium on brain calcium |
| 001959 |
P. R. Hof [États-Unis] ; A. Charpiot ; A. Delacourte [France] ; L. Buee ; D. Purohit ; D. P. Perl ; C. Bouras | Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism |
| 001961 |
F. Sellal [France] ; E. Hirsch [France] ; F. Lisovoski ; V. Mutschler ; M. Collard ; C. Marescaux | Contralateral disappearance of parkinsonian signs after subthalamic hematoma |
| 001997 |
S. Holemans [Belgique] ; F. Javoy [France] ; Yves Agid [France] ; E. C. Laterre ; J.-M. Maloteaux | [3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy |
| 001A10 |
G. K. Lloyd [France] ; A. Lowenthal ; F. Javoy-Agid ; J. Constantidinis | GABAA receptor complex function in frontal cortex membranes from control and neurological patients |
| 001A20 |
P. Gaspar [France] ; C. Duyckaerts [France] ; C. Alvarez ; F. Javoy-Agid ; B. Berger | Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease |
| 001A49 |
S. Dumas ; F. Javoy-Agid ; E. Hirsch ; Yves Agid [France] ; J. Mallet | Tyrosine hydroxylase gene expression in human ventral mesencephalon : detection of tyrosine hydroxylase messenger RNA in neurites |
| 001A58 |
D. T. Dexter [Royaume-Uni] ; A. Carayon ; M. Vidailhet ; M. Ruberg ; F. Agid ; Yves Agid [France] ; A. J. Lees ; F. R. Wells ; P. Jenner ; C. D. Marsden | Decreased ferritin levels in brain in Parkinson's disease |
| 001A60 |
M. Ruberg ; W. Mayo ; A. Brice ; C. Duyckaerts ; J. J. Hauw ; H. Simon ; M. Lemoal ; Yves Agid [France] | Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions |
| 001A83 |
M. O. Habert | Intérêt du débit sanguin cérébral régional dans le diagnostic différentiel des démences |
| 001A85 |
J.-C. Gautier | Homogreffes dans le cerveau humain. Données actuelles |
| 001A94 |
G. Renoux ; K. Biziere ; M. Renoux ; R. Steinberg ; J.-P. Kan ; J.-M. Guillaumin | Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice |
| 001B17 |
J.-P. Marc-Vergnes ; P. Celsis ; J. L. Montastruc ; J. F. Demonet ; A. Agniel ; O. Rascol ; G. Viallard ; B. Doyon ; A. Rascol | Hémodynamique cérébrale et pharmacologie clinique dans la maladie de Parkinson |
| 001B18 |
P. Celsis ; O. Rascol ; J. F. Demonet ; A. Agniel ; J. L. Montastruc ; J. P. Marc-Vergnes ; A. Rascol | Effet de la bromocriptine sur le débit sanguin cérébral dans la maladies de Parkinson |
| 001B24 |
S. Jegou ; F. Javoy-Agid ; C. Delbende ; D. Tranchand-Bunel ; D. H. Coy ; Yves Agid [France] ; H. Vaudry | Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects |
| 001B52 |
P. Dealy-Goyet ; J.-M. Zajac ; F. Javoy-Agid ; Yves Agid [France] ; B. P. Roques | Regional distribution of μ, σ and k opioid receptors in human brains from controls and parkinsonian subjects |
| 001B55 |
R. Cash ; T. Dennis ; R. L'Heureux ; R. Raisman ; F. Javoy-Agid ; B. Scatton | Parkinsons disease and dementia: norepinephrine and dopamine in locus ceruleus |
| 001B67 |
J. Epelbaum ; F. Javoy-Agid ; E. Hirsch ; J. J. Hauw ; C. Kordon ; S. Krantic ; Yves Agid [France] | Brain somatostatin concentrations do not decrease in progressive supranuclear palsy |
| 001B68 |
M. Ruberg ; A. Villageois ; A.-M. Bonnet ; B. Pillon ; F. Rieger ; Yves Agid [France] | Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems |
| 001B96 |
J. C. Monfort ; F. Javoy-Agid ; J. J. Hauw ; B. Dubois ; Yves Agid [France] | Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index |
| 001C01 |
B. Bokobza ; M. Ruberg ; B. Scatton ; F. Javoy-Agid ; Yves Agid [France] | [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy |
| 001C03 |
D. Rougemont ; J. C. Baron ; P. Collard ; P. Bustany ; D. Comar ; Yves Agid [France] | Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease |
| 001C05 |
P. Gaspar ; F. Gray | Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases |
